Avanti il prossimo

Riproduzione automatica

Prognostic factors for early-stage CTCL

5 Visualizzazioni • 08/09/23
Condividere
Incorporare
administrator
administrator
Iscritti
0

Evangelina Papadavid, MD, PhD, National and Kapodistrian University of Athens, Athens, Greece, gives an overview of the management of early-stage cutaneous T-cell lymphoma (CTCL), commenting on the role of prognostic factors, in particular the significance of plaques in early disease, and highlighting the Prospective Cutaneous Lymphoma International Prognostic Indices (PROCLIPI) trial. This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

Mostra di più
0 Commenti sort Ordina per
Commenti su Facebook

Avanti il prossimo

Riproduzione automatica